ASH1 mRNP-core factors form stable complexes in absence of cargo RNA at physiological conditions.
RNA Biol. 12, 233-237 (2015)
Asymmetric ASH1 mRNA transport during mitosis of budding yeast constitutes one of the best-studied examples of mRNA localization. Recently, 2 studies used in vitro motility assays to prove that motile ASH1 mRNA-transport complexes can be reconstituted entirely from recombinant factors. Both studies, however, differed in their conclusions on whether cargo RNA itself is required for particle assembly and thus activation of directional transport. Here we provide direct evidence that stable complexes do assemble in absence of RNA at physiologic conditions and even at ionic strengths above cellular levels. These results directly confirm the previous notion that the ASH1 transport machinery is not activated by the cargo RNA itself, but rather through protein-protein interactions.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Ash1 Mrna ; Myo4p ; Rna Localization ; She2p ; She3p ; Budding Yeast ; In Vitro Reconstitution ; Mrnp ; Macromolecular Assembly ; Myosin; Class-v Myosin; Messenger-rna; Binding Protein; Saccharomyces-cerevisiae; Translational Repression; Monomeric Myosin; Budding Yeast; Transport; Localization; Myo4p
Keywords plus
Language
english
Publication Year
2015
Prepublished in Year
HGF-reported in Year
2015
ISSN (print) / ISBN
1547-6286
e-ISSN
1555-8584
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 12,
Issue: 3,
Pages: 233-237
Article Number: ,
Supplement: ,
Series
Publisher
Landes Bioscience
Publishing Place
Philadelphia
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503091-001
Grants
Copyright
Erfassungsdatum
2015-04-02